-
SenseTime unveils first AI Chinese chess robot for family entertainment
Aug 11, 2022
Chinese artificial intelligence pioneer SenseTime has launched its first consumer product "SenseRobot", an AI interactive Xiangqi, or Chinese Chess, robot for family entertainment, further expanding its smart life product offerings.
-
ByteDance steps further into healthcare
Aug 11, 2022
Chinese tech behemoth ByteDance, owner of popular short video app TikTok, has acquired Beijing Amcare Medical Management Co Ltd, a high-end hospital group that provides women and children with medical services, in an effort to expand its reach into the healthcare segment.
-
Alibaba revenue beats expectations
Aug 10, 2022
Despite the challenges posed by the COVID-19 resurgence, Chinese tech heavyweight Alibaba Group Holding Ltd delivered better-than-expected financial results in the April-June period, saying it is determined to continuously invest in technology, customer service and logistics operations for sustainable and long-term growth.
-
Alibaba's dual primary listing in Hong Kong gains final approval
Aug 9, 2022
Alibaba Group Holding Ltd said on Monday night its voluntary conversion to a dual primary listing in Hong Kong has been confirmed by the Hong Kong stock exchange.
-
Update sets Huawei OS on growth trend
Aug 3, 2022
Huawei Technologies Co's self-developed operating system HarmonyOS is expected to see wider application in China, as it made progress in optimizing the system's performance, but more efforts are needed to build a robust software ecosystem for it, experts said on Thursday.
-
Sources: Xiaomi car-making project on track
Aug 3, 2022
Xiaomi Corp's $10 billion car-making project is progressing as per schedule, and a license is not needed at the moment.
-
Alibaba seeks dual-primary listing to foster more diversified investors
Jul 26, 2022
Alibaba Group seeks dual-primary listing in China's Hong Kong and the United State's New York, according to the company's Tuesday announcement on its official website.
-
Sinovac initiates clinical trial for quadrivalent influenza vaccine in Chile
Jul 20, 2022
Sinovac Biotech Ltd, a biopharmaceutical product provider in China, announced on Tuesday that a phase-3 clinical trial for its inactivated quadrivalent influenza vaccine was initiated in the Republic of Chile.